Palvella Therapeutics, Inc. announced the appointment of Vimal Patel, PharmD, as Senior Vice President of Medical Affairs. Dr. Patel brings more than 25 years of medical affairs leadership experience across dermatology and immunology with deep experience supporting late-stage development, commercial launches, and product lifecycle management. Prior to joining Palvella, Dr. Patel served as Dermatology Therapeutic Area Head, Medical Affairs at Incyte, where he led medical strategy across atopic dermatitis, vitiligo, and hidradenitis suppurativa.
In this role, he oversaw evidence generation, medical education, insights, and field medical execution. During his tenure, he played a key role in supporting the introduction and advancement of innovative dermatology therapies, including OPZELURA and povorcitinib, and held multiple leadership roles, including National Director of Field Medical Affairs and Executive Director of Medical Affairs. Prior to Incyte, Dr. Patel held senior leadership roles at Sun Pharma, where he served as Head of Medical Sales Liaisons and Medical Information for North America for ILUMYA® and Global Commercialization Lead for ODOMZO®, leading global asset integration and launch readiness.
Earlier in his career, he spent nearly 15 years at Johnson & Johnson, holding roles across medical information, accredited medical education, field leadership, and brand strategy, contributing to the success of multiple high-impact immunology and dermatology therapies, including REMICADE and STELARA. Dr. Patel holds a Bachelor of Science and a Doctor of Pharmacy degree from the Philadelphia College of Pharmacy.
